Related Experiment Video
Updated: Aug 15, 2026

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
Longitudinal changes in DTI-ALPS index are associated with clinical progression and brainstem atrophy in
Zhe Long1, Zhao Chen2, Huirong Peng3
1Department of Neurology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China; Clinical Medical Research Center for Stroke Prevention and Treatment of Hunan Province, Department of Neurology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China.
Background:
The perivascular and neurofluid-related tissue environment is implicated in neurodegeneration, but its clinical relevance in spinocerebellar ataxia type 3 (SCA3) remains unclear. We investigated alterations in diffusion tensor image analysis along the perivascular space (DTI-ALPS) across disease stages, and its longitudinal associations with clinical progression and brain atrophy.
Methods:
We included 129 SCA3 (44 preclinical, 85 ataxic) at baseline, 51 with longitudinal follow-up, and 78 controls. Cross-sectional, longitudinal, and structural equation modeling (SEM) analyses examined group differences, clinical correlates, progression, associations with regional brain volumes, and relationships among age, genetic burden, DTI-ALPS index, brainstem volume, and severity.
Results:
DTI-ALPS index was reduced in SCA3 and showed stage-dependent pattern. Ataxic SCA3 exhibited lower DTI-ALPS index than preclinical SCA3 and controls, whereas preclinical SCA3 did not differ from controls. Lower DTI-ALPS index was associated with greater clinical severity (r = -0.208, p < 0.05) and reduced volumes of the brainstem, thalamus, hippocampus, caudate, amygdala, pallidum, and putamen (p < 0.05). SEM showed that lower DTI-ALPS index was associated with greater clinical severity (β = -0.151, p < 0.05) and reduced brainstem volume (β = 0.160, p < 0.05). Longitudinally, lower baseline DTI-ALPS index was associated with faster clinical progression (β = -2.59, p < 0.01).
Conclusion:
Reduced DTI-ALPS index emerged predominantly during SCA3 symptomatic stage and was associated with greater severity, brainstem atrophy, and faster longitudinal disease progression. These findings supported DTI-ALPS index as a promising imaging marker for characterizing disease-related tissue environment changes and providing adjunctive prognostic information in SCA3.
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Alzheimer Disease l: Introduction
Alterations in Muscle Tone lll

